Jessica Riggleman

Sr. Director, Clinical and Regulatory Affairs - Mydecine Innovations Group

Jessica is the Senior Director of Clinical and Regulatory Affairs for Mydecine Innovations Group. She has spent the last ten years in the clinical research industry and has worked closely with cross-functional teams to develop clinical evidence generation strategies for global indication submissions. Jessica has supported and published research in robotics, orthopaedics, trauma, biologics, transcranial magnetic stimulation, and now psychedelic-assisted psychotherapy. She is enthusiastic about the future of integrative healing models in the international healthcare system. Jessica received her graduate degree in Clinical Research Administration from the George Washington University and resides in the Greater Philadelphia area in the United States.

Jessica Riggleman


  • Thursday - September 22, 2022 - 16:55

    Panel Discussion: The Future of Clinical Trials - The Role of Advanced Analytics and Artificial Intelligence


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now